Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Gilead Sciences, Inc.
(NQ:
GILD
)
51.94
USD
+0.91 (+1.78%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Gilead Sciences, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Volume in Focus: CenturyLink, Celgene, Gilead Sciences, Cisco
April 24, 2013
Dallas, TX -- (SBWIRE) -- 04/24/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Wednesday's ETF with Unusual Volume: BBH
April 24, 2013
The Biotech ETF (BBH) is seeing unusually high volume in afternoon trading Wednesday, with over 225,000 shares traded versus three month average volume of about 73,000. Shares of BBH were off about 3%...
Read More
category
ETFs
from
ETF Channel
StockCall Study on Gilead Sciences, NPS Pharma, InterMune, Seattle Genetics, and Halozyme Therapeutics
April 24, 2013
from
ACCESSWIRE
Bearish Moving Average Cross by Gilead Sciences (GILD)
April 24, 2013
from
Comtex SmarTrend® News Briefs
Gilead Sciences Inc (NASDAQ:GILD) Announces Results of Phase III Clinical Trials
April 24, 2013
Las Vegas, NV -- (SBWIRE) -- 04/24/2013 -- Gilead Sciences, Inc.(NASDAQ:GILD) announced the thorough results of four phase 3 clinical trials; NEUTRINO, FISSION, POSITRON and FUSION will be presented...
Read More
from
SBWire - Latest Press Releases
(JNJ) Will Johnson & Johnson Miss on Earnings?
April 23, 2013
Johnson & Johnson (JNJ) is scheduled to report its first quarter 2013 results on Apr 16, 2013... Visit StockBlogHub to view complete post.
Read More
category
Onyx Pharmaceuticals Inc
,
JNJ
,
Johnson & Johnson
, and 7 more.
from
Stock Blog Hub
Data from Phase 3 studies of Gilead's sofosbuvir for hepatitis C to be presented at 48th Annual EASL Meeting; Findings published online today in The New England Journal of Medicine
April 23, 2013
from
PR Newswire
UPDATE 1-AbbVie hepatitis C drugs knock out virus at 8 weeks
April 23, 2013
* Bristol-Myers shares up 1.2 percent after promising data
Read More
category
companyNews
from
Reuters: Company News
Noteworthy ETF Inflows: VUG, AAPL, GOOG, GILD
April 23, 2013
Symbols mentioned in this story: VUG, AAPL, GOOG, GILD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Read More
category
ETFs
from
ETF Channel
Gilead Sciences (GILD) Crosses Pivot Point Resistance at $54.43
April 23, 2013
from
Comtex SmarTrend® News Briefs
Datos de estudios de Fase 3 de sofosbuvir para hepatitis C de Gilead
April 23, 2013
from
Business Wire Spanish
Netflix Indicating Big Jump Pre-Market on Earnings Surprise - Top Earnings Stocks Ahead of the Bell: Power-One Inc., Goff Corporation, AMR Corporation, Fannie Mae, Vertex Pharmaceuticals
April 23, 2013
from
PR Newswire
Gilead (GILD) to Present Data from Four Sofosbuvir Phase 3s
April 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8269689 for the full story.
Read More
from
StreetInsider.com News Articles
Data from Phase 3 Studies of Gilead’s Sofosbuvir for Hepatitis C
April 23, 2013
from
Business Wire News Releases
Bristol-Myers oral hepatitis C regimen looks competitive -study
April 23, 2013
* 2 serious side effects likely unconnected to Bristol drugs
Read More
category
companyNews
from
Reuters: Company News
AbbVie hepatitis C drugs knock out virus at 8 weeks
April 23, 2013
April 23 (Reuters) - A combination of five oral drugs being tested by AbbVie Inc cured at least 88 percent of new patients with hepatitis C after only eight weeks of treatment, without raising...
Read More
category
companyNews
from
Reuters: Company News
Gilead Sciences - Trade Flow Report
April 23, 2013
NEW YORK (AVAFIN) -- Block trades serve as a useful indicator for investors trying ...
Read More
from
AVAFIN
Weekly Options Active On Microsoft
April 22, 2013
Today’s tickers: MSFT, GILD & PWER MSFT - Microsoft Corp. – Reporting from CNBC’s David Faber this morning that activist fund ValueAct Capital Management LLC has acquired a $2 billion stake in...
Read More
category
PWER
,
MSFT
,
Uncategorized
, and 1 more.
from
Phil’s Stock World
Moody's sees pick-up in pharmaceutical industry M&A in 2013
April 22, 2013
LONDON, April 23 (Reuters) - Cash-rich drug companies are likely to make more acquisitions in 2013 after a thin year for deals in 2012, ratings agency Moody's Investors Service said on Tuesday.
Read More
category
companyNews
from
Reuters: Company News
Maxim Group Raises Gilead Sciences (GILD) Price Target to $97
April 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8268370 for the full story.
Read More
from
StreetInsider.com News Articles
Biotech Mutual Funds Show ETFs Are The Place to Be
April 22, 2013
In March, we compared a a popular energy sector ETF and a comparable mutual fund with the idea being to figure out when relevant factors are considered, which vehicle is best for investors. That...
Read More
category
Benzinga
,
XLE
,
ETFs
, and 14 more.
from
Latest Articles from Benzinga.com
UPDATE: Morgan Stanley Raises PT on Gilead Sciences on Multiple Positive Factors
April 22, 2013
In a report published Monday, Morgan Stanley analyst Marshall Urist reiterated an Overweight rating on Gilead Sciences (NASDAQ: GILD ), and raised the price target from $46.00 to $65.00. In the report,...
Read More
category
Benzinga
,
Morgan Stanley
,
Price Target
, and 3 more.
from
Latest Articles from Benzinga.com
Stocks in News: Sequenom, Inc. (NASDAQ:SQNM), Taiwan Semiconductor Mfg. Co. Ltd. (ADR)(NYSE:TSM), Gilead Sciences, Inc.(NASDAQ:GILD)
April 22, 2013
Austin, TX -- (SBWIRE) -- 04/22/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues...
Read More
from
SBWire - Latest Press Releases
Insider Trading Watch for Microsoft, Bank of America, Halliburton, Gilead Sciences, Petroleo Brasileiro Petrobras S.A., and Home Depot
April 22, 2013
from
PR Newswire
Cheaper Gas, Airfare, Profits on Way as Commodities Slump Continues? - Top Small Cap Stock Focus Ahead of the Bell:
April 22, 2013
Harbor Island Development, Goff Corporation, AMR Corporation, Fannie Mae, Vertex Pharmaceuticals
Read More
from
PR Newswire
Active Buzzers: Citigroup Inc, Boston Scientific Corporation, Morgan Stanley, Gilead Sciences
April 21, 2013
from
ACCESSWIRE
A Look Ahead: This Week's ETFs to Watch
April 21, 2013
Market participants cannot look back on the dour performance turned in by U.S. stocks last week. The one where the S&P 500 slumped 2.1 percent and turned not only its worst weekly performance of 2013,...
Read More
category
Earnings
,
Specialty ETFs
,
Emerging Market ETFs
, and 26 more.
from
Latest Articles from Benzinga.com
Weekly Preview: Earnings Season Continues, Apple In Focus
April 19, 2013
Next week, earnings season continues as investors eye key earnings from technology behemoths Apple (NASDAQ: AAPL ) and chip maker Texas Instruments (NASDAQ: TXN ). Texas Instruments' earnings and...
Read More
category
S
,
Earnings
,
YUM
, and 90 more.
from
Latest Articles from Benzinga.com
NASDAQ 100's Top Performers: VRTX, GILD, QGEN
April 19, 2013
New York, April 19th (TradersHuddle.com) - The NASDAQ 100 Index is higher trading at 2776.98, which represents 1.28% versus its previous close. The index is mixed for the day with slightly more than...
Read More
from
TradersHuddle.com
News Buzz: AngloGold Ashanti, ISIS Pharmaceuticals, Astex Pharmaceuticals, Gilead Sciences
April 19, 2013
Dallas, TX -- (SBWIRE) -- 04/19/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.